Related Experiment Videos

Nitroblue tetrazolium test: early gross detection of human myocardial infarcts

Insights

The nitroblue tetrazolium (NBT) test can identify myocardial infarction damage in necropsy. This diagnostic method shows reliable results from 1 hour post-infarction, aiding in forensic pathology.

Area of Science:

  • Pathology
  • Forensic Medicine
  • Cardiovascular Science

Background:

  • Myocardial infarction diagnosis at necropsy can be challenging.
  • Histological methods are time-consuming and may not reflect gross changes.
  • A rapid, gross diagnostic test for fresh myocardial infarction is needed.

Purpose of the Study:

  • To evaluate the diagnostic utility of the nitroblue tetrazolium (NBT) test for gross detection of myocardial infarction at necropsy.
  • To determine the earliest time point at which NBT staining reliably indicates infarction.
  • To assess the stability of NBT staining for myocardial infarction over time postmortem.

Main Methods:

  • Hearts from 81 cases of suspected myocardial infarction were analyzed.
  • The nitroblue tetrazolium (NBT) staining technique was applied to gross specimens.
  • Staining patterns (diformazan, monogormazan) were correlated with clinical onset time.

Main Results:

  • NBT staining showed damaged heart muscle in suspected myocardial infarction cases.
  • Reliable staining was observed from 1 hour after clinical onset of infarction.
  • Seven out of 17 cases under 1 hour were negative; others showed characteristic staining.
  • Satisfactory results were obtained up to 3 days at ambient temperature and longer with cold storage.

Conclusions:

  • The NBT test is a valuable gross diagnostic tool for myocardial infarction at necropsy.
  • The test provides reliable results from approximately 1 hour post-infarction.
  • NBT staining is stable for several days, especially under refrigerated conditions, enhancing its forensic utility.

Related Concept Videos